Omega-3 Fatty Acids and Myocardial Inflammation in HFpEF: Preliminary Data and Next Steps
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:
• HFpEF
Locations
United States
Florida
University of Florida
RECRUITING
Gainesville
Contact Information
Primary
Ellen C Keeley, MD, MS
ellen.keeley@medicine.ufl.edu
800-265-0820
Backup
Vanessa H Scheuble
Vanessa.scheuble@medicine.ufl.edu
800-555-0820
Time Frame
Start Date: 2023-11-03
Estimated Completion Date: 2027-05-31
Participants
Target number of participants: 70
Treatments
Experimental: Single arm study of subjects with HFpEF
Subjects with HFpEF undergo a baseline gadolinium based cardiac MRI and the same day they undergo an iron infusion. Three days later they return for a follow-up cardiac MRI and the iron that has been administered 72 hours ago serves as the contrast media
Related Therapeutic Areas
Sponsors
Leads: University of Florida
Collaborators: American Heart Association